ABT today
$109.29-$1.17 (-1.06%)close Nov 11, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bullish
1 hourBullish
15 minBullish
5 minConsolidating
Daily trend turns up above $117.34
Key levels
Resistance$112.47
Resistance$109.35
Support$105.88
Support$102.48
Latest news & SEC filings
ProductAbbott gains U.S. and European clearances for new defibrillator lead
AnalystBank of America Lifts Its Target on Abbott to $125
ProductAbbott brings COVID-19 and flu A/B self-test to Canada
DealAbitareIn sets buyback of some shares and wind-down plan
All ABT news →About Abbott
Abbott is a healthcare company that discovers, develops, manufactures, and sells many different products. It operates through four segments: branded generic pharmaceuticals sold outside the U.S., laboratory testing equipment and assays, pediatric and adult nutrition products, and medical devices for cardiovascular, diabetes, and neuromodulation care. Customers include hospitals, laboratories, physicians, wholesalers, retailers, government agencies, and consumers worldwide.
Based on the company's 10-K filed Feb 20, 2026.
NYSE · Healthcare
ABBOTT LABORATORIES (ABT)
What Is the Price Target for ABT?
SEPT Low Target
$115.00
SEPT Mid Target
$120.00
SEPT High Target
$134.00
Analyst Consensus
$120.00
Is ABT a Buy or Sell Right Now?
Thesis
- •Revenue growing 5.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ABT.
Start Free Trial →Is ABT Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$108.28
24
Moat Score
NONE
4/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with ABT?
Insider Signal
NEUTRAL
1 buys / 3 sells (90d)
Congress Signal
BUYING
7 buys / 12 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Moreland Mary K | officer | Sale | 3,500 | $406K | Nov 5, 2026 |
| Conroy Kevin T | director | Sale | 52,507 | $5.5M | Sep 23, 2026 |
| Ford Robert B | director officer | Buy | 151,869 | $6.7M | Aug 25, 2026 |
| Ford Robert B | director officer | Buy | 246,963 | $14.8M | Aug 25, 2026 |
| Ford Robert B | director officer | Sale | 218,535 | $25.3M | Aug 25, 2026 |
| Ford Robert B | director officer | Sale | 180,297 | $20.9M | Aug 25, 2026 |
| Cushman Elizabeth C. | officer | Sale | 560 | $53K | Jun 27, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ABT Growth Story
Revenue YoY
5.7%
3yr Revenue CAGR
0.5%
EPS Growth YoY
-51.31%
FCF Growth YoY
16.4%
Revenue Trend
ACCELERATING
Dark Pool Trades for ABT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ABT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:28:25 | $109.29 | 27,000 | $$3.0M | SELL |
| 21:21:59 | $109.29 | 1,554 | $$170K | SELL |
| 21:04:16 | $109.29 | 1,972 | $$216K | SELL |
| 21:04:16 | $109.29 | 2,660 | $$291K | SELL |
| 21:04:16 | $109.29 | 3,830 | $$419K | SELL |
5 dark pool trades shown · $$4.0M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ABT
PREVIEWSEPT Investing provides real-time options flow tracking for ABT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $120 | Mar 19 | 128 | $$350 | 1 | SWEEP |
| CALL | $120 | Mar 19 | 128 | $$1750 | 5 | SWEEP |
| CALL | $120 | Mar 19 | 128 | $$350 | 1 | SWEEP |
| CALL | $120 | Mar 19 | 128 | $$350 | 1 | SWEEP |
| CALL | $120 | Mar 19 | 128 | $$1750 | 5 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ABBOTT LABORATORIES (ABT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ABT — frequently asked questions
What is ABT stock price today?
ABBOTT LABORATORIES (ABT) is at $109.29, down 1.06% (-$1.17) at the Nov 11, 2026 close.
Why is ABT stock moving today?
Latest ABT news — Nov 11, 2026: Abbott gains U.S. and European clearances for new defibrillator lead · Nov 10, 2026: Bank of America Lifts Its Target on Abbott to $125
Why did ABT stock move on Oct 21, 2026?
Abbott Laboratories reported third-quarter adjusted EPS of $1.42, matching expectations, with revenue of $13.013 billion slightly beating the $12.998 billion estimate. The company narrowed its fiscal 2026 adjusted EPS outlook to $5.50-$5.55 and guided fourth-quarter adjusted EPS to $1.62-$1.67, whose midpoint is just below the $1.64 analyst estimate.
What is the ABT price target?
The average analyst price target for ABT is $120.00, ranging from $115 to $134, based on 19 analysts. Latest: BofA Analyst raises on Nov 10, 2026.
What do analysts rate ABT?
Analyst ratings for ABT: 2 Buy, 33 Hold, 1 Sell — consensus Hold.
Did ABT beat earnings?
ABT last reported on Oct 21, 2026: EPS $1.42 vs $1.42 expected — in line.
What is ABT's P/E ratio?
ABT trades at a P/E of 41.0 vs a Healthcare average of 17.1.
Does ABT pay a dividend?
Yes. ABT's dividend yield is 1.88%.
What are ABT support and resistance levels?
Support: $105.88, $102.48, $97.67. Resistance: $109.35, $112.47, $117.07.
What are insiders doing with ABT?
Insider activity: NEUTRAL, 1 buys and 3 sells in the last 90 days.
What is the latest news on ABT?
Nov 11, 2026: Abbott gains U.S. and European clearances for new defibrillator lead · Nov 10, 2026: Bank of America Lifts Its Target on Abbott to $125 · Nov 10, 2026: Abbott brings COVID-19 and flu A/B self-test to Canada